Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sun Pharma Of India Extends Deadline For Shares Of Israel’s Taro

This article was originally published in PharmAsia News

Executive Summary

India's Sun Pharmaceuticals has extended its offer for the shares of Israel's Taro Pharmaceuticals after failing to obtain all the shares by Oct. 3. The new deadline would be Sun's third for the firm, after encountering legal problems with the first one. The effort is a hostile takeover by Sun, which had a merger agreement with Taro earlier this year that fell apart. Sun already has 38 percent of Taro stock and is seeking to increase that to 48 percent, giving it 60 percent of voting rights and control of the Israeli firm. Legal issues involving the case are expected to be taken up by Dec. 15. (Click here for more

Related Content




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts